CN101843753B - Chinese medicament for treating angina - Google Patents
Chinese medicament for treating angina Download PDFInfo
- Publication number
- CN101843753B CN101843753B CN2009102421517A CN200910242151A CN101843753B CN 101843753 B CN101843753 B CN 101843753B CN 2009102421517 A CN2009102421517 A CN 2009102421517A CN 200910242151 A CN200910242151 A CN 200910242151A CN 101843753 B CN101843753 B CN 101843753B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- chinese
- radix
- fine powder
- chinese medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention relates to a Chinese medicament for treating angina, and belongs to the field of Chinese medicaments for treating cardio-cerebral-vascular system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: sandalwood, lucid ganoderma, Chinese angelica, radix rehmanniae praeparata, radix pseudo-ginseng and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, and warming, freeing and dissipating cold and relieving pain, and has the advantages of obvious effect, exact medicinal effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of cardiovascular and cerebrovascular systems.
Background technology
Present be intended to treat the anginal field of Chinese medicines, exist some problems: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.So that many patient with angina pectoris are subjected to the torment of feeling of oppression and pain in the chest for a long time, the probability that myocardial infarction takes place increases, and has influenced life quality.
At problem set forth above, the invention provides the anginal Chinese medicine of a kind of treatment, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, the anginal Chinese medicine of a kind of treatment adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Lignum Santali Albi 4---30 parts of 30 portions of Ganodermas 2---12 parts of Radix Angelicae Sinensis 4---
20 parts of Radix Rehmanniae Preparata 4---30 portions of Radix Notoginseng 3---
The anginal Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, Lignum Santali Albi, Radix Angelicae Sinensis, Radix Rehmanniae Preparata are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Rehmanniae Preparata the body resistance strengthening and constitution consolidating in the side, benefiting QI and nourishing blood, tranquilizing by nourishing the heart, enhancing human body immunity power; Radix Angelicae Sinensis, Radix Notoginseng nourshing blood and promoting blood circulation, blood-activating analgetic, coronary artery dilating, coronary blood flow increasing; Be aided with Lignum Santali Albi eliminating turbid pathogen with aromatics, the logical cold expelling of temperature with pain relieving.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the merit of the logical dispersing cold for relieving pain of temperature, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Lignum Santali Albi 70 kairine sesames 30 gram Radix Angelicae Sinensis 70 grams
Radix Rehmanniae Preparata 70 gram Radix Notoginseng 50 grams
Weight in accordance with regulations, with conventional water extraction process Lignum Santali Albi, Radix Angelicae Sinensis, Radix Rehmanniae Preparata are extracted, make extractum fine powder 63 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 510 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Lignum Santali Albi 160 kairine sesames 80 gram Radix Angelicae Sinensis 160 grams
Radix Rehmanniae Preparata 160 gram Radix Notoginseng 100 grams
By above-mentioned same method, make 1085 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Lignum Santali Albi 300 kairine sesames 120 gram Radix Angelicae Sinensis 300 grams
Radix Rehmanniae Preparata 300 gram Radix Notoginseng 200 grams
By above-mentioned same method, make 2107 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
7 parts of 3 parts of Radix Angelicae Sinensis of 7 portions of Ganodermas of Lignum Santali Albi
4 parts of 7 portions of Radix Notoginseng of Radix Rehmanniae Preparata
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
20 parts of 8 parts of Radix Angelicae Sinensis of 20 portions of Ganodermas of Lignum Santali Albi
15 parts of 20 portions of Radix Notoginseng of Radix Rehmanniae Preparata
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science angina pectoris, through 7 routine clinical observations.Selecting the tcm diagnosis angina pectoris is standard: feeling of oppression and pain in the chest, and nervous cardiopalmus, limbs fatigue, the visible T ripple of electrocardiogram is unusual during outbreak.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 4 examples, women's 3 examples do not have other serious disease, and the age is 51 years old-82 years old, 66.4 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, and heart district is comfortable, and angor uncomfortable in chest is obviously alleviated or disappeared, and Electrocardioscopy is no abnormal.
2, effective: body constitution strengthens to some extent, and angor uncomfortable in chest is alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom is obviously improved.7 philtrums of clinical experiment, produce effects 3 people, effective 3 people, invalid 1 people, total effective rate 85.7%.
Claims (1)
1. the anginal Chinese medicine of treatment is characterized in that, described Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Lignum Santali Albi 4---30 parts of 30 portions of Ganodermas 2---12 parts of Radix Angelicae Sinensis 4---
20 parts of Radix Rehmanniae Preparata 4---30 portions of Radix Notoginseng 3---
The anginal Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, Lignum Santali Albi, Radix Angelicae Sinensis, Radix Rehmanniae Preparata are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Make Chinese medicine granules, capsule, watered pill, Tabules.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102421517A CN101843753B (en) | 2009-12-09 | 2009-12-09 | Chinese medicament for treating angina |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102421517A CN101843753B (en) | 2009-12-09 | 2009-12-09 | Chinese medicament for treating angina |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101843753A CN101843753A (en) | 2010-09-29 |
| CN101843753B true CN101843753B (en) | 2011-07-20 |
Family
ID=42768691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102421517A Expired - Fee Related CN101843753B (en) | 2009-12-09 | 2009-12-09 | Chinese medicament for treating angina |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101843753B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104906515A (en) * | 2015-06-29 | 2015-09-16 | 张保菊 | Traditional Chinese medicine composition for treating stenocardia and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1202364A (en) * | 1997-06-13 | 1998-12-23 | 湖南中医学院第一附属医院 | Oil solutions for remitting angina pectoris |
-
2009
- 2009-12-09 CN CN2009102421517A patent/CN101843753B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1202364A (en) * | 1997-06-13 | 1998-12-23 | 湖南中医学院第一附属医院 | Oil solutions for remitting angina pectoris |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101843753A (en) | 2010-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843661B (en) | Chinese medicament for treating angina | |
| CN101843712B (en) | Chinese medicament for treating angina | |
| CN101843660B (en) | Chinese medicament for treating tachycardia | |
| CN101843753B (en) | Chinese medicament for treating angina | |
| CN101554443B (en) | Traditional Chinese medicine for treating angina | |
| CN101843644B (en) | Chinese medicament for treating tachycardia | |
| CN101843717B (en) | Chinese medicament for treating coronary disease | |
| CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101843759B (en) | Oral Chinese medicament for treating fracture | |
| CN101843720B (en) | Chinese medicament for treating angina | |
| CN101843755A (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101850034B (en) | Chinese medicament for treating angina | |
| CN101843647B (en) | Chinese medicament for treating angina | |
| CN101843645B (en) | Chinese medicament for treating tachycardia | |
| CN101843793B (en) | Chinese medicament for treating tachycardia | |
| CN101849985B (en) | Chinese medicament for treating tachycardia | |
| CN101843758B (en) | Chinese medicament for treating coronary disease | |
| CN101843673B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101564476B (en) | Chinese medicament for treating coronary heart disease | |
| CN101843768B (en) | Chinese medicament for treating climacteric syndromes | |
| CN101843672B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101843798B (en) | Oral Chinese medicament for treating fracture | |
| CN101850054B (en) | Chinese medicament for treating diabetic heart diseases | |
| CN101843792A (en) | Chinese medicament for treating angina | |
| CN101843700A (en) | Chinese medicament for treating coronary disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO., Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20130701 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130701 Address after: 226500 Rugao province Jiangsu City Jiangan Town Road No. 166. Patentee after: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO., LTD. Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110720 Termination date: 20151209 |
|
| EXPY | Termination of patent right or utility model |